Latest Capital Efficiency News

Maronan Metals bolsters its financial and technical position with a $22 million strategic investment from Kinterra Capital, accelerating infill drilling that confirms high-grade silver-lead and copper-gold mineralisation at the Maronan Project.

Fenix Resources has secured crucial regulatory and environmental approvals for its Beebyn-W10 iron ore mine, adjacent to Beebyn-W11, forming the Beebyn Hub. This milestone underpins the company’s 3-Year Production Plan aiming for up to 6 million tonnes per annum by FY28.

Perenti's subsidiary AMS, through AMAX Ltd, has secured a six-month contract extension at the Iduapriem Gold Mine in Ghana, including the sale of mining equipment valued between A$30 million and A$40 million to AngloGold Ashanti.

Ironbark Balanced Income Limited (ASX:IBC) has initiated a fresh on-market buy-back targeting up to 10 million shares, representing roughly 10% of its issued capital, set to run from July 2026 through July 2027.

PC Gold has settled the purchase of a 64-room accommodation camp near its Spring Hill Gold Project, cutting capital costs and enabling faster operational ramp-up. The company also announced a 500,000 performance rights issue to align employee incentives with key project milestones.

Medallion Metals is fast-tracking gold production at its Forrestania Gold Project by launching an Early Production Strategy in Q4 2026, nearly nine months ahead of schedule. This move leverages existing infrastructure to generate cashflow and de-risk the upcoming Ravensthorpe ore processing.

Kinetiko Energy is progressing rapidly from exploration to production with a major onshore gas discovery in South Africa, targeting first commercial compressed natural gas by late 2027 through a phased, capital-efficient development.

Tusker Minerals has outlined a multi-billion-tonne JORC Exploration Target at its Douala Basin Project in Cameroon, highlighting a globally significant rutile-rich mineral sands system with strong infrastructure advantages.

Nova Minerals has completed engineering and design for its Estelle antimony pilot plant in Alaska, moving swiftly into procurement and construction with equipment en route to site.

OncoSil Medical has completed key manufacturing validation cycles with Cyclotek, paving the way for scalable Australian production of its OncoSil™ device. With a $2.1 million capital investment, the company aims to boost margins and supply chain control ahead of commercial launch in late 2026.

Hastings Technology Metals and JV partner Wyloo have unveiled an updated Definitive Feasibility Study for the Yangibana Rare Earths Project, revealing robust economics and a streamlined path to production with substantial infrastructure already in place.

Patrys has assigned its deoxymab intellectual property to Yale University in a deal granting it half of all future commercialisation revenue, reducing capital needs while keeping long-term upside.